Your browser is no longer supported. Please, upgrade your browser.
GSK GlaxoSmithKline plc daily Stock Chart
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E15.44 EPS (ttm)2.70 Insider Own0.20% Shs Outstand2.48B Perf Week-0.52%
Market Cap104.15B Forward P/E13.98 EPS next Y2.98 Insider Trans0.00% Shs Float2.50B Perf Month-1.63%
Income6.78B PEG4.68 EPS next Q0.47 Inst Own12.50% Short Float0.40% Perf Quarter-1.60%
Sales44.31B P/S2.35 EPS this Y22.80% Inst Trans6.37% Short Ratio2.16 Perf Half Y-7.48%
Book/sh6.64 P/B6.28 EPS next Y1.81% ROA6.90% Target Price47.70 Perf Year6.98%
Cash/sh2.45 P/C17.03 EPS next 5Y3.30% ROE54.00% 52W Range31.43 - 48.25 Perf YTD-11.26%
Dividend1.89 P/FCF26.48 EPS past 5Y10.30% ROI14.30% 52W High-13.58% Beta0.72
Dividend %4.53% Quick Ratio0.60 Sales past 5Y8.00% Gross Margin68.20% 52W Low32.68% ATR0.72
Employees99437 Current Ratio0.90 Sales Q/Q18.70% Oper. Margin21.50% RSI (14)56.59 Volatility1.00% 1.43%
OptionableYes Debt/Eq2.44 EPS Q/Q87.40% Profit Margin15.30% Rel Volume0.60 Prev Close41.65
ShortableYes LT Debt/Eq1.89 Earnings- Payout27.80% Avg Volume4.66M Price41.70
Recom2.00 SMA200.40% SMA502.78% SMA200-2.34% Volume2,777,744 Change0.12%
Feb-12-20Downgrade Shore Capital Hold → Sell
Jan-16-20Downgrade Barclays Equal Weight → Underweight
Dec-02-19Initiated SVB Leerink Outperform
Nov-21-19Upgrade UBS Neutral → Buy
Oct-11-19Upgrade Cantor Fitzgerald Hold → Buy
Sep-03-19Upgrade Societe Generale Sell → Buy
Sep-03-19Resumed Citigroup Neutral
Aug-13-19Resumed JP Morgan Neutral
Jun-17-19Resumed Morgan Stanley Underweight
Mar-08-19Downgrade Shore Capital Buy → Hold
Feb-22-19Downgrade UBS Buy → Neutral
Jan-14-19Downgrade Exane BNP Paribas Outperform → Neutral
Dec-11-18Resumed Jefferies Buy
Oct-09-18Initiated Guggenheim Neutral
Aug-30-18Downgrade Liberum Buy → Hold
Apr-04-18Upgrade Exane BNP Paribas Neutral → Outperform
Mar-22-18Upgrade Morgan Stanley Underweight → Equal-Weight
Feb-09-18Upgrade Kepler Reduce → Hold
Nov-06-17Downgrade Investec Buy → Hold
Oct-26-17Downgrade BofA/Merrill Buy → Neutral
Jun-06-20 12:03PM  
Jun-05-20 02:00PM  
01:22PM  
Jun-04-20 11:38AM  
10:23AM  
10:23AM  
04:30AM  
Jun-03-20 06:04PM  
07:02AM  
05:56AM  
Jun-01-20 09:57AM  
09:00AM  
07:47AM  
May-29-20 06:47PM  
09:45AM  
09:37AM  
07:48AM  
02:52AM  
May-28-20 08:00PM  
05:50PM  
05:32PM  
03:10PM  
11:34AM  
04:00AM  
02:51AM  
May-27-20 12:00AM  
May-26-20 11:53AM  
10:52AM  
07:52AM  
May-24-20 08:21AM  
May-23-20 09:15AM  
May-22-20 03:43PM  
10:31AM  
10:13AM  
07:46AM  
07:29AM  
05:37AM  
May-21-20 10:41PM  
10:00PM  
07:11PM  
03:48PM  
02:24PM  
02:04PM  
05:17AM  
May-20-20 12:00PM  
11:49AM  
08:11AM  
May-19-20 02:59PM  
11:39AM  
11:39AM  
10:44AM  
07:02AM  
May-18-20 08:32PM  
03:10PM  
11:20AM  
10:03AM  
05:05AM  
02:58AM  
02:29AM  
May-15-20 07:16PM  
02:23PM  
06:46AM  
May-14-20 02:05PM  
01:27PM  
11:51AM  
11:33AM  
11:16AM  
08:47AM  
May-13-20 11:11PM  
07:38PM  
04:51PM  
04:42PM  
11:57AM  
08:16AM  
May-11-20 10:53AM  
05:38AM  
May-10-20 09:47AM  
May-08-20 06:16PM  
11:42AM  
08:25AM  
May-07-20 01:57PM  
11:24AM  
09:31AM  
03:10AM  
03:10AM  
May-06-20 02:50PM  
11:17AM  
11:11AM  
09:35AM  
09:35AM  
08:17AM  
May-05-20 11:16PM  
May-03-20 04:13AM  
May-01-20 05:18PM  
Apr-30-20 10:44AM  
09:37AM  
09:11AM  
08:51AM  
07:19AM  
Apr-29-20 06:31PM  
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; and Sanofi SA. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLCFormer 10% OwnerOct 18Buy28.00357,1429,999,9762,982,855Oct 22 05:36 PM
GLAXOSMITHKLINE PLCDirectorSep 10Buy45.00177,7777,999,9652,170,327Sep 12 04:18 PM
GLAXOSMITHKLINE PLCDirectorJul 01Buy15.00333,3334,999,9952,633,772Jul 02 04:13 PM